We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 94.26%
This Fund
S&P 500
This Quarter Est. Return
+21.35%
1 Year Est. Return
+94.26%
3 Year Est. Return
+310.51%
5 Year Est. Return
+306.13%
10 Year Est. Return
+3,783.92%
AUM
$2.04B
AUM Growth
+$120M
Cap. Flow
-$149M
Cap. Flow %
-7.33%
Top 10 Hldgs %
47.27%
Holding
257
New
21
Increased
32
Reduced
47
Closed
104

Top Buys

Rank Stock Value
1
U icon
Unity
U
+$16.4M
2
TRAX
First Tracks Biotherapeutics
TRAX
+$14M
3
SE icon
Sea Limited
SE
+$11.9M
4
NU icon
Nu Holdings
NU
+$10.1M
5
GOSS icon
Gossamer Bio
GOSS
+$9.54M

Top Sells

Rank Stock Value
1
ASTH icon
Astrana Health
ASTH
+$17.6M
2
LLY icon
Eli Lilly
LLY
+$15.3M
3
GXO icon
GXO Logistics
GXO
+$14.8M
4
FOLD
Amicus Therapeutics
FOLD
+$11.2M
5
APLS
Apellis Pharmaceuticals
APLS
+$10.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.9%
2 Healthcare 24.5%
3 Financials 7.3%
4 Consumer Discretionary 7.28%
5 Technology 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LULU icon
201
PUT
lululemon athletica
LULU
$11B
– –
-25,000
Closed -$3.83M
MBOT icon
202
Microbot Medical
MBOT
$98.1M
– –
-170,000
Closed -$410K
MDXH icon
203
MDxHealth
MDXH
$66M
– –
-97,000
Closed -$223K
MRAM icon
204
Everspin Technologies
MRAM
$407M
– –
-70,000
Closed -$615K
NEOV icon
205
NeoVolta
NEOV
$230M
– –
-170,000
Closed -$524K
NTGR icon
206
NETGEAR
NTGR
$566M
– –
-100,000
Closed -$2.18M
OBIO icon
207
Orchestra BioMed
OBIO
$328M
– –
-185,000
Closed -$786K
IMDX
208
Insight Molecular Diagnostics
IMDX
$134M
– –
-29,000
Closed -$95.1K
ONL
209
Orion Office REIT
ONL
$149M
– –
-208,134
Closed -$447K
OSS icon
210
One Stop Systems
OSS
$234M
– –
-60,000
Closed -$454K
OWLT icon
211
Owlet
OWLT
$142M
– –
-65,000
Closed -$334K
PLBY icon
212
Playboy Inc
PLBY
$138M
– –
-150,000
Closed -$228K
PPIH
213
Perma-Pipe International
PPIH
$240M
– –
-30,000
Closed -$894K
PRE icon
214
Prenetics Global
PRE
$407M
– –
-40,000
Closed -$773K
PTGX icon
215
CALL
Protagonist Therapeutics
PTGX
$9.39B
– –
-15,100
Closed -$1.59M
PYPL icon
216
CALL
PayPal
PYPL
$44.6B
– –
-42,300
Closed -$1.91M
RAIL icon
217
FreightCar America
RAIL
$221M
– –
-55,000
Closed -$438K
RANI icon
218
Rani Therapeutics
RANI
$97M
– –
-487,168
Closed -$358K
RILY icon
219
BRC Group Holdings
RILY
$273M
– –
-60,000
Closed -$439K
RDNW
220
RideNow Group
RDNW
$215M
– –
-42,000
Closed -$297K
RPID icon
221
Rapid Micro Biosystems
RPID
$60.7M
– –
-120,773
Closed -$274K
RSVR
222
Reservoir Media
RSVR
$584M
– –
-90,000
Closed -$881K
RVMD icon
223
PUT
Revolution Medicines
RVMD
$44.5B
– –
-50,100
Closed -$4.87M
RXO icon
224
RXO
RXO
$3.31B
– –
-180,000
Closed -$2.63M
SAIC icon
225
Saic
SAIC
$5.29B
– –
-19,000
Closed -$1.8M
7 8
9
10 11

Similar funds

SFI
Siemens Fonds Invest Munich, Germany $2.04B AUM 40.78% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $2.04B AUM 33.06% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
C
Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
JCM
Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return

683 Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, 683 Capital Management held 257 positions worth $2.04B, up 6.3% from $1.92B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

683 Capital Management withdrew a net $149M in Q2 2026, closing 104 positions and reducing 47 holdings. Its most notable exit was Eli Lilly, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 47% a quarter earlier, followed by Healthcare and Financials.

Against the trend, 683 Capital Management opened a new position in Unity worth $17.6M.

  • 683 Capital Management's largest Q2 2026 buy was Unity: 615,000 shares worth $17.6M.
  • 683 Capital Management added most to Gossamer Bio in Q2 2026, an estimated $9.54M increase.
  • 683 Capital Management's biggest Q2 2026 reduction was Astrana Health, cutting an estimated $17.6M.
  • 683 Capital Management fully exited Eli Lilly in Q2 2026, selling an estimated $15.3M.
  • 683 Capital Management's ten largest holdings make up 47% of its $2.04B portfolio in Q2 2026.
  • 683 Capital Management opened 21 new positions and closed 104 in Q2 2026.
  • 683 Capital Management's portfolio value rose 6.3% quarter-over-quarter to $2.04B.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.